ReviewInternational journal of women's dermatology2026
Exploring the link between atopic dermatitis and allergic contact dermatitis in patients with skin of color: a scoping review.
Review in International journal of women's dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with skin of color (SOC) experience increased rates of atopic dermatitis (AD) than the general population and suffer from more severe disease. In addition, patients with SOC experience higher sensitization rates to particular allergens and are patch tested less frequently. Because of these factors, there is a need to assess whether allergic contact dermatitis (ACD) contributes to the higher disease severity in SOC patients with AD. Objective: The goal of this review is to systematically evaluate the potential association between ACD and AD in the SOC population. Methods: A systematic search of PubMed (date of last search: July 2025) was performed to identify studies of patients with SOC referred for patch testing to various allergens for suspected ACD. AD prevalence and clinical outcomes were required for inclusion. Data collected and provided in table format included: author, type and year of study, race/ethnicity of subjects, eczema prevalence, patch test positivity, specific allergen sensitivities, and allergen source. Results: Four out of the 8 manuscripts meeting inclusion criteria provided evidence for a higher eczema prevalence in patients with SOC who were referred for patch testing; however, larger, well-designed studies are required to fully elucidate the true associations among patients with SOC, AD, and ACD. Limitations: The limited number and heterogeneity of studies and the potential underreporting of both ACD and AD in patients with SOC may contribute to potential bias. Further, this is a scoping review and does not provide additional data analysis to support any particular conclusion. Conclusion: Dermatologists must continue to counsel SOC patients with AD regarding potential disease-modifying ACD-related exposures.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.